Cargando…

An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant

Detalles Bibliográficos
Autores principales:	Zhang, Hong-Qing, Zhang, Ya-Nan, Zhang, Zhe-Rui, Chen, Xiao-Ling, Hu, Yan-Yan, Shi, Yu-Jia, Wang, Jing, Deng, Cheng-lin, Zhang, Bo, Li, Xiao-Dan, Ye, Han-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747704/ https://www.ncbi.nlm.nih.gov/pubmed/36513647 http://dx.doi.org/10.1038/s41392-022-01246-x

Ejemplares similares

A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles
por: Zhang, Ya-Nan, et al.
Publicado: (2020)

Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity
por: Avogadri, Francesca, et al.
Publicado: (2010)

The Adjuvant Activity of Alphavirus Replicons Is Enhanced by Incorporating the Microbial Molecule Flagellin into the Replicon
por: Knudsen, Maria L., et al.
Publicado: (2013)

Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle
por: Kamrud, K. I., et al.
Publicado: (2010)

A Vaccinia Virus Recombinant Transcribing an Alphavirus Replicon and Expressing Alphavirus Structural Proteins Leads to Packaging of Alphavirus Infectious Single Cycle Particles
por: Sánchez-Puig, Juana M., et al.
Publicado: (2013)

Architecture of the SARS coronavirus prefusion spike
por: Beniac, Daniel R, et al.
Publicado: (2006)

In Vitro Inhibition of Alphaviruses by Lycorine
por: Li, Na, et al.
Publicado: (2021)

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins
por: Wang, Min, et al.
Publicado: (2017)

Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens
por: van de Wall, Stephanie, et al.
Publicado: (2018)

Cryo-EM structures of alphavirus conformational intermediates in low pH–triggered prefusion states
por: Chen, Chun-Liang, et al.
Publicado: (2022)

Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis
por: Wang, Xiaoyan, et al.
Publicado: (2005)

Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses
por: Yang, Yongping, et al.
Publicado: (2021)

SARS-CoV-2 replicon for high-throughput antiviral screening
por: Zhang, Qiu-Yan, et al.
Publicado: (2021)

Rapid, Specific Detection of Alphaviruses from Tissue Cultures Using a Replicon-Defective Reporter Gene Assay
por: Li, Jiangjiao, et al.
Publicado: (2012)

Correction: Rapid, Specific Detection of Alphaviruses from Tissue Cultures Using a Replicon-Defective Reporter Gene Assay
por: Li, Jiangjiao, et al.
Publicado: (2012)

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
por: Huo, Jiandong, et al.
Publicado: (2020)

An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats
por: Langereis, Martijn A., et al.
Publicado: (2021)

A human antibody potently neutralizes RSV by targeting the conserved hydrophobic region of prefusion F
por: Yi, Chunyan, et al.
Publicado: (2023)

Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
por: Pohjala, Leena, et al.
Publicado: (2011)

P19-14. Recombinant alphavirus replicon particles as a platform to evaluate immunogenicity of early transmitted clade C virus envelopes
por: Franti, M, et al.
Publicado: (2009)

Alphavirus Replicon Particle Vaccine Breaks B Cell Tolerance and Rapidly Induces IgG to Murine Hematolymphoid Tumor Associated Antigens
por: Su, Hsuan, et al.
Publicado: (2022)

Modulating donor mitochondrial fusion/fission delivers immunoprotective effects in cardiac transplantation
por: Tran, Danh T., et al.
Publicado: (2021)

An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity
por: Fluckiger, Anne-Catherine, et al.
Publicado: (2021)

Characterization of untranslated regions of the salmonid alphavirus 3 (SAV3) genome and construction of a SAV3 based replicon
por: Karlsen, Marius, et al.
Publicado: (2009)

Development and characterization of a Rift Valley fever virus cell–cell fusion assay using alphavirus replicon vectors
por: Filone, Claire Marie, et al.
Publicado: (2006)

Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants
por: Cacciottolo, Mafalda, et al.
Publicado: (2023)

Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures
por: Melero, Roberto, et al.
Publicado: (2020)

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
por: Hsieh, Ching-Lin, et al.
Publicado: (2020)

Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes
por: Hsieh, Ching-Lin, et al.
Publicado: (2020)

Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation
por: Wrapp, Daniel, et al.
Publicado: (2020)

Continuous flexibility analysis of SARS-CoV-2 Spike prefusion structures
por: Melero, Roberto, et al.
Publicado: (2020)

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
por: Wrapp, Daniel, et al.
Publicado: (2020)

Differential Dynamic Behavior of Prefusion Spike Glycoproteins of Sars Coronaviruses 1 and 2
por: Moradi, Mahmoud, et al.
Publicado: (2021)

Alphavirus Replicon DNA Vectors Expressing Ebola GP and VP40 Antigens Induce Humoral and Cellular Immune Responses in Mice
por: Ren, Shoufeng, et al.
Publicado: (2018)

Development and Immunoprotection of Bacterium-like Particle Vaccine against Infectious Bronchitis in Chickens
por: Zhang, Pengju, et al.
Publicado: (2023)

SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern
por: Lu, Mijia, et al.
Publicado: (2022)

Structural dynamics of prefusion spike protein of SARS-CoV-2 and its variants
por: Derakhshani-Molayousefi, Mortaza, et al.
Publicado: (2022)

High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
por: Tan, Timothy J.C., et al.
Publicado: (2022)

High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
por: Tan, Timothy J. C., et al.
Publicado: (2023)

Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants
por: Liu, Haitao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q91jbe3nt2io5fspe3qc6me3ld